Theodoropoulos PA - Search Results

1

Recognition motifs for importin 4 [(L)PPRS(G/P)P] and importin 5 [KP(K/Y)LV] binding, identified by bio-informatic simulation and experimental in vitro validation.

Panagiotopoulos AA, Kalyvianaki K, Tsodoulou PK, Darivianaki MN, Dellis D, Notas G, Daskalakis V, Theodoropoulos PA, Panagiotidis CΑ, Castanas E, Kampa M. Panagiotopoulos AA, et al. Among authors: theodoropoulos pa. Comput Struct Biotechnol J. 2022 Oct 26;20:5952-5961. doi: 10.1016/j.csbj.2022.10.015. eCollection 2022. Comput Struct Biotechnol J. 2022. PMID: 36382187 Free PMC article.

2

Membrane androgen binding sites are preferentially expressed in human prostate carcinoma cells.

Stathopoulos EN, Dambaki C, Kampa M, Theodoropoulos PA, Anezinis P, Delakas D, Delides GS, Castanas E. Stathopoulos EN, et al. Among authors: theodoropoulos pa. BMC Clin Pathol. 2003 Jan 30;3:1. doi: 10.1186/1472-6890-3-1. BMC Clin Pathol. 2003. PMID: 12588669 Free PMC article.

3

Estrogen exerts neuroprotective effects via membrane estrogen receptors and rapid Akt/NOS activation.

Alexaki VI, Charalampopoulos I, Kampa M, Vassalou H, Theodoropoulos P, Stathopoulos EN, Hatzoglou A, Gravanis A, Castanas E. Alexaki VI, et al. FASEB J. 2004 Oct;18(13):1594-6. doi: 10.1096/fj.04-1495fje. Epub 2004 Aug 2. FASEB J. 2004. PMID: 15289442

4

Membrane androgen receptor activation induces apoptotic regression of human prostate cancer cells in vitro and in vivo.

Hatzoglou A, Kampa M, Kogia C, Charalampopoulos I, Theodoropoulos PA, Anezinis P, Dambaki C, Papakonstanti EA, Stathopoulos EN, Stournaras C, Gravanis A, Castanas E. Hatzoglou A, et al. Among authors: theodoropoulos pa. J Clin Endocrinol Metab. 2005 Feb;90(2):893-903. doi: 10.1210/jc.2004-0801. Epub 2004 Dec 7. J Clin Endocrinol Metab. 2005. PMID: 15585562

5

Opposing effects of estradiol- and testosterone-membrane binding sites on T47D breast cancer cell apoptosis.

Kampa M, Nifli AP, Charalampopoulos I, Alexaki VI, Theodoropoulos PA, Stathopoulos EN, Gravanis A, Castanas E. Kampa M, et al. Among authors: theodoropoulos pa. Exp Cell Res. 2005 Jul 1;307(1):41-51. doi: 10.1016/j.yexcr.2005.02.027. Epub 2005 Apr 7. Exp Cell Res. 2005. PMID: 15922725

6

Membrane testosterone binding sites in prostate carcinoma as a potential new marker and therapeutic target: study in paraffin tissue sections.

Dambaki C, Kogia C, Kampa M, Darivianaki K, Nomikos M, Anezinis P, Theodoropoulos PA, Castanas E, Stathopoulos EN. Dambaki C, et al. Among authors: theodoropoulos pa. BMC Cancer. 2005 Nov 17;5:148. doi: 10.1186/1471-2407-5-148. BMC Cancer. 2005. PMID: 16293185 Free PMC article.

7

Comparison of a multiplex, bead-based fluorescent assay and immunofluorescence methods for the detection of ANA and ANCA autoantibodies in human serum.

Nifli AP, Notas G, Mamoulaki M, Niniraki M, Ampartzaki V, Theodoropoulos PA, Kopnitsky MJ, Castanas E. Nifli AP, et al. Among authors: theodoropoulos pa. J Immunol Methods. 2006 Apr 20;311(1-2):189-97. doi: 10.1016/j.jim.2006.02.004. Epub 2006 Mar 3. J Immunol Methods. 2006. PMID: 16554066

8

Activation of membrane androgen receptors potentiates the antiproliferative effects of paclitaxel on human prostate cancer cells.

Kampa M, Kogia C, Theodoropoulos PA, Anezinis P, Charalampopoulos I, Papakonstanti EA, Stathopoulos EN, Hatzoglou A, Stournaras C, Gravanis A, Castanas E. Kampa M, et al. Among authors: theodoropoulos pa. Mol Cancer Ther. 2006 May;5(5):1342-51. doi: 10.1158/1535-7163.MCT-05-0527. Mol Cancer Ther. 2006. PMID: 16731768

9

Quercetin exhibits a specific fluorescence in cellular milieu: a valuable tool for the study of its intracellular distribution.

Nifli AP, Theodoropoulos PA, Munier S, Castagnino C, Roussakis E, Katerinopoulos HE, Vercauteren J, Castanas E. Nifli AP, et al. Among authors: theodoropoulos pa. J Agric Food Chem. 2007 Apr 18;55(8):2873-8. doi: 10.1021/jf0632637. Epub 2007 Mar 27. J Agric Food Chem. 2007. PMID: 17385883

10

Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development.

Alexaki VI, Notas G, Pelekanou V, Kampa M, Valkanou M, Theodoropoulos P, Stathopoulos EN, Tsapis A, Castanas E. Alexaki VI, et al. J Immunol. 2009 Nov 1;183(9):5948-56. doi: 10.4049/jimmunol.0901186. Epub 2009 Oct 14. J Immunol. 2009. PMID: 19828625

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

62 results

Search Page